A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
NCT 05277168 Brief Summary The study (dose escalation/expansion) is being conducted to…
Read more arrow_forwardNCT 05277168 Brief Summary The study (dose escalation/expansion) is being conducted to…
Read more arrow_forwardNCT 05800015 Brief Summary This study is researching an investigational drug…
Read more arrow_forwardNCT 05608291 Brief Summary This study is researching an experimental drug called…
Read more arrow_forwardNCT 05355298 Brief Summary This is a multicentre, open label, two-part study…
Read more arrow_forwardNCT 03067181 Brief Summary This phase III trial studies how well active…
Read more arrow_forwardNCT 05725291 Brief Summary This first-in-human study will evaluate the Maximum…
Read more arrow_forwardNCT 05906862 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forwardNCT 05876754 Brief Summary A Phase 3b research study to consolidate the…
Read more arrow_forwardNCT 03897881 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 03340129 Brief Summary This is a phase II, open label, randomised…
Read more arrow_forward